digital health startups weight loss glp-1 Riding the Wegovy wave: The shifting focus to GLP-1s to tap the $150bn drug market The Impact of GLP-1 Agonists
Description
Avcil M, elik A
Does insurance cover GLP-1 weight loss medications

Lying down tends to make nausea worse

Among GLP-1 users, the 18-month risk of ION was about 8.5 cases per 10,000 people, compared with 5.5 cases per 10,000 among patients taking SGLT2 inhibitors

hold patent rights via the work of DSK and NHG

Some GLP-1s are now approved to reduce these risks in individuals with obesity, even without diabetes